MILANESE, Giulio
 Distribuzione geografica
Continente #
NA - Nord America 9.154
EU - Europa 7.295
AS - Asia 4.099
SA - Sud America 905
AF - Africa 264
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
Totale 21.738
Nazione #
US - Stati Uniti d'America 8.963
IT - Italia 2.978
RU - Federazione Russa 1.365
SG - Singapore 1.322
VN - Vietnam 815
CN - Cina 747
BR - Brasile 710
UA - Ucraina 601
DE - Germania 439
HK - Hong Kong 388
IE - Irlanda 355
FR - Francia 320
SE - Svezia 319
TR - Turchia 218
FI - Finlandia 215
DK - Danimarca 200
GB - Regno Unito 171
BD - Bangladesh 132
CI - Costa d'Avorio 130
KR - Corea 121
NL - Olanda 120
CA - Canada 92
IN - India 92
AR - Argentina 68
MX - Messico 67
PL - Polonia 42
JP - Giappone 40
ZA - Sudafrica 37
ES - Italia 36
IQ - Iraq 35
EC - Ecuador 30
BE - Belgio 26
CO - Colombia 26
MA - Marocco 26
ID - Indonesia 23
PK - Pakistan 22
CL - Cile 21
VE - Venezuela 21
UZ - Uzbekistan 20
AT - Austria 19
PH - Filippine 19
LY - Libia 16
DZ - Algeria 15
LT - Lituania 15
EU - Europa 11
IL - Israele 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
SA - Arabia Saudita 10
TN - Tunisia 10
JO - Giordania 9
PE - Perù 9
CR - Costa Rica 8
PY - Paraguay 8
RO - Romania 8
AL - Albania 7
AU - Australia 7
EG - Egitto 7
MY - Malesia 7
TW - Taiwan 7
UY - Uruguay 7
KE - Kenya 6
AZ - Azerbaigian 5
GR - Grecia 5
MD - Moldavia 5
SI - Slovenia 5
TH - Thailandia 5
BH - Bahrain 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
GE - Georgia 4
HR - Croazia 4
JM - Giamaica 4
KZ - Kazakistan 4
NP - Nepal 4
PA - Panama 4
SN - Senegal 4
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
IR - Iran 3
KG - Kirghizistan 3
LB - Libano 3
NI - Nicaragua 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
CG - Congo 2
EE - Estonia 2
LV - Lettonia 2
MK - Macedonia 2
MN - Mongolia 2
MT - Malta 2
NG - Nigeria 2
PR - Porto Rico 2
PS - Palestinian Territory 2
Totale 21.711
Città #
Dallas 1.781
Ashburn 1.182
Singapore 777
Jacksonville 560
Chandler 522
San Jose 431
Hong Kong 369
Dublin 351
Boardman 346
New York 309
Fairfield 296
Ho Chi Minh City 265
Council Bluffs 253
Beijing 234
Milan 234
Wilmington 234
Des Moines 209
Hanoi 183
The Dalles 176
Rome 170
Seattle 154
Los Angeles 146
Lauterbourg 140
Abidjan 130
Ann Arbor 130
Moscow 128
Lawrence 118
Princeton 118
San Mateo 113
Woodbridge 111
Hefei 88
Houston 86
Helsinki 76
Munich 76
Naples 67
São Paulo 64
Cambridge 63
Ancona 62
Buffalo 62
Turin 58
Chicago 50
Orem 46
Palermo 45
San Diego 41
Turku 39
Centro 38
Montreal 36
Bologna 35
Florence 35
Haiphong 35
Da Nang 34
London 33
Santa Clara 30
Perugia 29
Warsaw 29
Frederico Westphalen 28
Bari 27
Tokyo 27
Brussels 26
Porto 26
Mexico City 25
Frankfurt am Main 24
Rio de Janeiro 24
Berlin 23
Pesaro 23
Chennai 22
Denver 22
Johannesburg 22
Toronto 21
Nuremberg 20
Tashkent 20
Brooklyn 19
Rapagnano 19
Salt Lake City 19
Shanghai 19
Washington 19
Poplar 18
Stockholm 18
Caserta 17
Phoenix 17
Can Tho 16
Manchester 16
Marche 16
Amsterdam 15
Boston 15
Catania 15
Pune 15
Buenos Aires 14
Columbus 14
Curitiba 14
Guangzhou 14
Hải Dương 14
Napoli 14
Verona 14
Pescara 13
Petritoli 13
Porto Alegre 13
Tripoli 13
Vienna 13
Biên Hòa 12
Totale 12.255
Nome #
110 SERUM LEVELS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR IN PATIENTS WITH PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA 2.230
Isosorbide dinitrato per la disfunzione erettile 1.319
L’invasione linfovascolare e l’infiltrazione perineurale come fattori prognostici predittivi di recidiva biochimica precoce dopo prostatectomia radicale 883
Analisi della perdita di eterozigosi (LOH) nelle neoplasie della vescica mediante elettroforesi capillare 271
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 203
Clinical progression of megacalycosis in a girl with a solitary kidney: The lesson learned 189
A conservative approach to perineal Fournier's Gangrene 182
Clinical performance and utility of a NNMT-based urine test for bladder cancer 181
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 177
Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy? 174
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 172
Neoplasie vescicale pT1G2-3: risultati della nostra esperienza dopo TURV seguita da che mio- o immunoprofilassi e follow-up medio di 4 anni 171
Analisi dell’instabilità dei microsatelliti nelle neoplasie della vescica mediante elettroforesi capillare. esperienza preliminare 170
Normal human macula densa morphology and cell turnover: A histological, ultrastructural, and immunohistochemical investigation 170
Robot-assisted segmental ureterectomy with psoas hitch ureteral reimplantation: Oncological, functional and perioperative outcomes of case series of a single centre 165
Biomarkers for VEGF-Targeted Therapy in Renal Cell Carcinoma: Critical Review of Level of Evidence and Up to Date 164
Correlation between urodyanamics and perineal ultrasound in female patients with urinary incontinence. 162
An update of in-vivo application of artificial intelligence and robotics for percutaneous nephrolithotripsy. Results from a systematic review 161
Neutrophil‑to‑lymphocyte ratio may be associated with the outcome in patients with prostate cancer 160
Carcinoma prostatico solitario della zona di transizione. 156
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 156
Evidence for the presence of a1 adrenoreceptor subtypes in the human ureter 155
464 Cost comparison for different medical treatments in conservative — expulsive therapy of distal ureteral stones 154
Valutazione della qualità di vita al follow-up dopo cistectomia radicale: derivazioni urinarie a confronto, la nostra esperienza. 152
FUNCTIONAL OUTCOME EVALUATION AFTER REHABILITATION OF PELVIC FLOOR AFTER ROBOTIC RADICAL PROSTATECTOMY (RARP) VERSUS RETROPUBIC RADICAL PROSTATECTOMY (RRP) 152
Dual energy CT combined with infrrede spectroscopy: imaging to predict urinary stones composition and stiffness 147
Case report: A hybrid technique for a safe nephrectomy in a giant kidney angiomyolipoma 146
Association between trauma and cancer of the testis: the importance of self-palpation of the testis for the early detection: two case reports. 146
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 145
Do DNA methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up. 145
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 144
Extracorporeal shock wave lithotripsy, ureterolithotripsy, and percutaneous nephrolithotripsy challenges in managing spinal cord neuropathy patients. Lessons learned from a scoping review 143
Angiogenesis as prognostic factor in small renal tumors 143
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 142
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 141
370Ultrasound evaluation of bladder neck complex alterations in chronic prostatitis/chronic pelvic pain syndrome 140
465 Alpha1 adrenoceptor subtypes in men juxtavesical ureters: Molecular and pharmacological characterization 139
602 SIMULTANEOUS TURB-TURP IN PATIENTS WITH BLADDER CANCER AND BPH: A PROSPECTIVE RANDOMIZED TRIAL ON RELAPSES OCCURRENCE AND TREATMENT-RELATED QUALITY OF LIFE 137
PEC-OME of the prostate: case report 137
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 137
Is spinal anesthesia a safe alternative for retrograde intrarenal surgery for stone disease in daily practice? 136
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 136
Le biopsie mirate su lesioni ipoecogene migliorano la correlazione del grading tra biopsia e prostatectomia radicale. 132
The influence of lead exposure on male semen parameters: A systematic review and meta-analysis 131
Unusual clinical scenarios in Urology and Andrology 131
Randomized trial on the efficacy of tamsulosin, nifedipine and phloroglucinol in medical-expulsive therapy of distal ureteral calculi. 130
Concomitant robot-assisted laparoscopic surgeries for upper and lower urinary tract malignancies: a comprehensive literature review 129
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 128
Prognostic role of Furhman grade and vascular endothelia growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens 125
Identificazione dell’enzima nicotinamide n-metiltransferasi quale marker molecolare del carcinoma renale a cellule chiare. 125
Novità nel trattamento della calcolosi urinaria 124
I frammenti di biopsia prostatica: caratteristiche, dimensioni e numero 124
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 124
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 123
77 Soluble urokinase receptor expression in urine is a prognostic marker in patients with transitional cell carcinoma of the bladder 123
Current evidence on surgical management for benign prostatic hyperplasia in renal transplant recipients: a systematic review 122
Safety and efficacy of transurethral resection of prostate gland up to 150 mls: a prospective comparative study with 1 year follow-up 120
Correlation between ultrasound alterations of the preprostatic sphincter and symptoms in patients with chronic prostatitis-chronic pelvic pain syndrome 120
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database 120
Impact of ureteral sheath on success and complications after RIRS: does size matter? 120
IMPORTANCE OF LENGTH OF RADIAL EXTRAPROSTATIC EXTENSION IN 101 PATIENTS PT3A R0 LVI0 N0 119
Prognostic role of microvessel density (MVD), vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1alfa (HIF-1alfa) in patients with conventional clear cell renal carcinoma after radical nephrectomy in a long term follow-up 118
PSA-IGM BASED ALGORITHM (IXIP SCORE) DURING FOLLOW-UP OF ACTIVE SURVEILLANCE 118
THE ACCURACY OF (CU)-C-64-PSMA PET/TC IN IDENTIFYING THE SITE OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH LOW PSA VALUES (< 2 ng/ml) 116
Catechol-o-methyltransferase, a promising diagnostic marker for non-invasive detection of human urothelial carcinoma 115
Simultaneous Inguinal Hernia Repair with Monofilament Polypropylene Mesh during Robot-Assisted Radical Prostatectomy: Results from a Single Institute Series 115
Iperespressione della 5-lipossigenasi nel carcinoma renale a cellule chiare. 115
Identification of paraoxonase-2 as potential biomarker for bladder cancer 115
Migrazione di stadio in campioni di prostatectomia radicale: analisi di 15 anni. 113
Conservative management of juxtavesical calculi with tamsulosin 112
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 112
Non dilated obstructive uropathy secondary to tur-syndrome in patient with solitary kidney 111
Efficacy and safety of alfa-1-blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a prospective study 110
Fragments of prostatic biopsy: characteristics, dimensions, and number. 110
Increased expression of 5-lipoxygenase is common in clear cell renal carcinoma 109
IMPACT OF INTEGRATED CARE PATHWAY FOR BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS IN MARCHE REGION 107
INTRADUCTAL CARCINOMA IN LOW- AND INTERMEDIATE-RISK PROSTATE CANCER: PATHOLOGICAL AND CLINICAL RELEVANCE 107
Does Alexis Wound Protector/Retractor Reduce the Risk of Surgical Site Infections After Open Radical Cystectomy for Bladder Cancer? Results From a Single Center, Comparative Study 106
Ruolo prognostico della metilazione globale e della acetilazione nelle neoplasie renali a cellule chiare pT1a trattate con nefrectomia parziale 106
NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER: DIFFERENCES IN CLINICAL AND PATHOLOGICAL RESPONCE 106
PERI-OPERATIVE OUTCOMES OF OPEN VERSUSROBOT-ASSISTED SIMPLE PROSTATECTOMY: RESULTS FROMTWO HIGH-VOLUME CENTRES 105
FOCAL THERAPY OF LOCALIZED PROSTATE CANCER WITH "FUSION" INTEGRATED PATH AND HIGH INTENSITY FOCUSED ULTRASOUND (HIFU): INITIAL EXPERIENCE 105
Improving clinical diagnostic accuracy and management of False penile fractures characterizing typical clinical presentation: a systematic review and meta-analysis 104
Prognostic role of global DNA-methylation and histone acetylation in pT1a clear cell renal carcinoma in partial nephrectomy specimens 104
DIFFERENCES IN CLINICAL AND PATHOLOGICAL RESPONSE TO NEOADIUVANT CHEMOTHERAPY IN PATIENTS WITH INVASIVE BLADDER CANCER 104
Evaluation of epidermal growth factor receptor and urokinase-type plasminogen activator receptor in serum of prostate cancer patients 103
Infezione virale da Herpes virus come possibile causa di ritenzione urinaria. Caso clinico 103
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 102
α1-Blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: A prospective randomized study. 102
The pathway of isolated seminal vesicle invasion has a different impact on biochemical recurrence after radical prostatectomy and pelvic lymphadenectomy 101
Diffusione ghiandolare del carcinoma prostatico: schema di rappresentazione stereografica su reperti ecografici e bioptici 101
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 101
Seminal vesicle invasion in pT3bN0cM0 prostate cancer patients treated with radical prostatetectomy: Impact of Ohori patterns of invasion on biochemical recurrence 100
Does Hounsfield Unit have any significance in predicting intra and postoperative outcomes in retrograde intrarenal surgery using holmium and Thulium fiber laser? A critical analysis of results from the FLEXible ureteroscopy Outcomes Registry (FLEXOR) 100
Efficacy of 1-Year Cavacurmin® Therapy in Reducing Prostate Growth in Men Suffering from Lower Urinary Tract Symptoms 100
Medical-expulsive therapy for distal ureterolithiasis: a randomized prospective study on the role of corticosteroids used in combination with tamsulosin. Simplified treatment regimen and health-related quality of life. 99
Increased urokinase-type plasminogen activator receptor and epidermal growth factor receptor in serum of patients with prostate cancer 99
Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma 99
Quality of life in the follow-up after radical cystectomy: comparison between different urinary diversions 98
Intraprostatic spread of prostatic carcinoma: stereographic representation based on ultrasonography and biopsy findings. 98
Totale 17.152
Categoria #
all - tutte 84.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022939 51 221 29 55 18 51 25 88 79 80 48 194
2022/20232.059 159 179 163 140 141 349 22 130 534 42 123 77
2023/20241.887 251 65 97 235 224 349 48 93 29 140 133 223
2024/20253.434 372 272 195 107 200 133 345 189 653 215 353 400
2025/20269.574 554 884 1.477 792 799 563 1.369 678 1.251 563 288 356
2026/2027204 204 0 0 0 0 0 0 0 0 0 0 0
Totale 22.028